CRVS: Corvus Pharmaceuticals, Inc. Stock

by  •  • Comments Off on CRVS: Corvus Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 66.69
Enterprise Value ($M) 54.07
Book Value ($M) 38.68
Book Value / Share 0.79
Price / Book 1.72
NCAV ($M) 21.09
NCAV / Share 0.43
Price / NCAV 3.16

Profitability (mra)
Return on Invested Capital (ROIC) -0.65
Return on Assets (ROA) -0.46
Return on Equity (ROE) -0.55

Liquidity (mrq)
Quick Ratio 4.07
Current Ratio 4.07

Balance Sheet (mrq) ($M)
Current Assets 27.96
Assets 45.55
Liabilities 6.87
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -23.33
Net Income -27.03
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -23.93
Cash from Investing 15.54
Cash from Financing 7.86

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G Samlyn Capital, Llc 5.10
02-13 13G/A Miller Richard A Md 7.19 18.64

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-19 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-18 43,747 14,873 294.14
2024-04-17 38,532 112,527 34.24
2024-04-16 28,885 91,660 31.51
2024-04-15 7,354 69,358 10.60

(click for more detail)

Similar Companies
CRMD – CorMedix Inc. CRON – Cronos Group Inc.
CRSP – CRISPR Therapeutics AG CVAC – CureVac N.V.
EGRX – Eagle Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io